The Auto Channel
The Largest Independent Automotive Research Resource
The Largest Independent Automotive Research Resource
Official Website of the New Car Buyer

IRIS Marketing Campaign Targets New Overseas Opportunities; Company To Participate In MEDICA 2000 Trade Fair in Dusseldorf, Germany

20 November 2000

IRIS Marketing Campaign Targets New Overseas Opportunities; Company To Participate In MEDICA 2000 Trade Fair in Dusseldorf, Germany

    CHATSWORTH, Calif.--Nov. 20, 2000--International Remote Imaging Systems, Inc., also known as IRIS (AMEX: IRI), announced today that it plans to launch a marketing campaign targeting Europe and other regions around the world at the four-day MEDICA 2000 trade fair in Dusseldorf, Germany, opening Wednesday, November 22.
    "IRIS is the leader in fully-automated urinalysis systems and consistently maintains that position by seeking out new opportunities in the worldwide market for clinical diagnostic products and medical technology," said Dr. John A. O'Malley, Chairman, President and Chief Executive Officer of International Remote Imaging Systems, Inc. "IRIS already dominates 85 per cent of the automated sediment analysis market in the United States and is focused on increasing its significant overseas presence through new marketing and distribution channels."
    Dr. O'Malley said that MEDICA 2000, an international congress and world forum for medical practices and hospitals, is a perfect opportunity for increasing IRIS' exposure in Europe and selected markets worldwide. The trade fair features 3,200 exhibitors, mainly medical distributors, from 60 countries and attracts more than 100,000 visitors from around the world.
    "IRIS enjoys increasing sales and growth due to a strong product line that includes urinalysis testing systems and other medical devices marketed through an extensive system of distributors," Dr. O'Malley stated. "Interacting with our international distributors and attracting new ones to sell our product in selected regions around the world is a step the Company is taking toward its goal of establishing an even more formidable presence in Europe and other overseas markets."

    IRIS is a leader in automated urinalysis technology with more than 450 of its workstations installed in major medical institutions throughout the world. IRIS manufactures the only clinical analyzers using real-time video flow imaging, displaying microscopic images on a video screen; the systems are operated by touch screen interfaces pioneered by the Company for use in urinalysis. IRIS imaging systems use patented and proprietary automated intelligent microscopy (AIM) technology for automating microscopic procedures. IRIS enables clinical laboratory technologists to rapidly and efficiently analyze and process specimens automatically, significantly reducing the costly and time-consuming manual steps required for microscopic analysis.
    Its StatSpin(R) subsidiary, acquired in 1996, excels as a maker of innovative centrifuges and blood analysis products. Thirty-five thousand of its micro centrifuge systems have been sold to date. More than 600 major medical institutions worldwide, along with thousands of smaller hospitals, commercial laboratories, clinics, doctors' offices, veterinary labs and research institutions use StatSpin's products. StatSpin manufactures the world's fastest blood separator (30 seconds). Its bench top centrifuges are dedicated to applications for manual specimen preparation for coagulation, cytology, hematology and urinalysis. StatSpin has been providing centrifuges to the veterinary market through a company which provides sample and analysis systems and recently shipped the 10,000th centrifuge to this market.

    This news release contains forward-looking statements made in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. IRIS refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.